These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25133279)

  • 21. [Factor Xa inhibitor (rivaroxaban and drugs under investigation)].
    Atarashi H
    Nihon Rinsho; 2013 Jan; 71(1):119-25. PubMed ID: 23631182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
    Lip GY; Kongnakorn T; Phatak H; Kuznik A; Lanitis T; Liu LZ; Iloeje U; Hernandez L; Dorian P
    Clin Ther; 2014 Feb; 36(2):192-210.e20. PubMed ID: 24508420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke.
    Bowry R; Fraser S; Archeval-Lao JM; Parker SA; Cai C; Rahbar MH; Grotta JC
    Stroke; 2014 Mar; 45(3):880-3. PubMed ID: 24425115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel oral anticoagulants in secondary prevention of stroke.
    Diener HC; Easton JD; Hankey GJ; Hart RG
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. European Society of Cardiology congress 2011.
    Cardiovasc J Afr; 2011; 22(5):287-8, 291-2. PubMed ID: 21983959
    [No Abstract]   [Full Text] [Related]  

  • 28. Angioedema due to the new oral anticoagulant rivaroxaban.
    Altin C; Ozturkeri OA; Gezmis E; Askin U
    Ann Card Anaesth; 2014; 17(2):173-4. PubMed ID: 24732626
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
    Contractor T; Levin V; Martinez MW; Marchlinski FE
    Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What are the new therapeutic alternatives to warfarin in atrial fibrillation?
    Kamran SH; Muzammil SM; Kamal AK
    J Pak Med Assoc; 2013 Jan; 63(1):129-30. PubMed ID: 23865151
    [No Abstract]   [Full Text] [Related]  

  • 31. Atrial fibrillation choices. Picking an anti-clotting drug.
    Mayo Clin Health Lett; 2014 Jun; 32(6):4-5. PubMed ID: 25029747
    [No Abstract]   [Full Text] [Related]  

  • 32. Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation".
    Stöllberger C; Finsterer J
    Thromb Haemost; 2013 Sep; 110(3):496-500. PubMed ID: 23803875
    [No Abstract]   [Full Text] [Related]  

  • 33. Help prevent Afib-related stroke. New anticoagulants for atrial fibrillation prove as effective, or even better than, warfarin--and easier to use.
    Duke Med Health News; 2014 Sep; 20(9):3. PubMed ID: 25358137
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral anticoagulants for atrial fibrillation: Which one to choose?
    Ribowsky JH; Ismael AG
    Adv NPs PAs; 2012 May; 3(5):31-2. PubMed ID: 22670305
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
    Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
    Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneus splenic rupture in a patient treated with rivaroxaban.
    Gonzva J; Patricelli R; Lignac D
    Am J Emerg Med; 2014 Aug; 32(8):950.e3. PubMed ID: 24612597
    [No Abstract]   [Full Text] [Related]  

  • 38. Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients.
    Baruch L; Sherman O
    Ann Pharmacother; 2013 Sep; 47(9):1210-2. PubMed ID: 24259738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation--not so NICE in Ireland!
    Collins DR; Coughlan T
    Ir Med J; 2012; 105(7):229-31. PubMed ID: 23008880
    [No Abstract]   [Full Text] [Related]  

  • 40. Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications.
    Barrios V; Escobar C
    Expert Rev Cardiovasc Ther; 2013 Feb; 11(2):129-41. PubMed ID: 23405833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.